Shares of Healios K.K. (OTCMKTS:HLOSF – Get Free Report) traded up 5.6% during trading on Thursday . The stock traded as high as 0.99 and last traded at 0.99. 200 shares changed hands during trading, a decline of 84% from the average session volume of 1,260 shares. The stock had previously closed at 0.94.
Healios K.K. Stock Performance
The firm’s fifty day simple moving average is 0.94 and its 200 day simple moving average is 1.26.
About Healios K.K.
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.
Further Reading
- Five stocks we like better than Healios K.K.
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- MarketBeat Week in Review – 4/22 – 4/26
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Stocks Leading the U.S. Agriculture Comeback
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.
